MedPath
NMPA Approval

Ritlecitinib Tosylate Capsules

国药准字HJ20230118

October 18, 2023

Drug Information

甲苯磺酸利特昔替尼胶囊

乐复诺

胶囊剂

50mg(按C₁₅H₁₉N₅O计)

化学药品

October 18, 2023

October 17, 2028

Company Information

Applicant Company

PFIZER INC.

66 Hudson Boulevard East, New York, NY 10001 United States of America

Manufacturing Company

Mooswaldallee 1, Freiburg im Breisgau 79090 GERMANY

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲苯磺酸利特昔替尼胶囊 - NMPA 批准文号 | MedPath